NEUROBLOC

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Ireland, Lithuania, Poland, Romania

Active ingredients

The drug NEUROBLOC contains one active pharmaceutical ingredient (API):

1 Botulinum toxin type B UNII 0Y70779M1F - RIMABOTULINUMTOXINB

Botulinum toxin type B is a neuromuscular blocking agent indicated for the treatment of cervical dystonia. When injected directly into a muscle, it causes a localised paralysis that gradually reverses over time. Read about Botulinum toxin type B

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEUROBLOC Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1197918, 1197929, 1197930
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 01166001, 01166002, 01166003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 117394, 165814, 396454
Country: FR	Base de données publique des médicaments	Identifier(s): 63181966
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1029581, 1029582, 1029583
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100312009
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51605001, W51605002, W51605003